Key result
Type 2 diabetes links to QT prolongation and heightened arrhythmia risk through distinct pathophysiological mechanisms.
Key points are not available for this paper at this time.
No takes yet. Share an insight, caveat, or question.
Jules C. Hancox (2017) studied this question. Type 2 diabetes is examined to explore the underlying pathophysiological basis for associated human QT interval prolongation and arrhythmia risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: